Accounts and Notes Receivable, Net

12 Months Ended

Dec. 31, 2024

ACCOUNTS AND NOTES RECEIVABLE - NET


(In millions)	December 31, 2024		December 31, 2023
Accounts receivable – trade1	$	4,448	$	4,210
Notes receivable – trade1,2	167		119
Other3	1,061		1,159
Total accounts and notes receivable - net	$	5,676	$	5,488

1.Accounts and notes receivable – trade are net of allowances of $179 million and $205 million at December 31, 2024 and 2023, respectively.

2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of Seed and Crop Protection products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2024 and 2023, there were no significant impairments related to current loan agreements.

3.Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $144 million and $131 million as of December 31, 2024 and 2023, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the years ended December 31, 2024 and 2023 respectively:


(In millions)
Balance at December 31, 2022	$	194
Net provision for credit losses	11
Other - net of write-offs charged against allowance	—
Balance at December 31, 2023	$	205
Net provision for credit losses	39
Other - net of write-offs charged against allowance	(65)
Balance at December 31, 2024	$	179

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Balance Sheets.

Trade receivables sold under these agreements were $131 million, $112 million, and $134 million for the years ended December 31, 2024, 2023 and 2022, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of December 31, 2024 and 2023 were $15 million and $2 million, respectively. The net proceeds received were included in cash provided by (used for) operating activities, in the Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense) - net in the Consolidated Statements of Operations. The loss on sale of receivables were $9 million and $17 million, and $19 million for the years ended December 31, 2024, 2023 and 2022, respectively. See Note 16 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information on the company’s guarantees.